Sign in

The hormone that regulates sleep may help treat blood cancer

Updated on: Sep 2, 2017, 16:28:40 IST
Asian News International, Washington D.C. | By
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link
Melatonin boosts the immune response against cancer cells, inhibits cancer cell growth and protects healthy cells from the toxic effects of chemotherapy. (Shutterstock)
Melatonin boosts the immune response against cancer cells, inhibits cancer cell growth and protects healthy cells from the toxic effects of chemotherapy. (Shutterstock)

According to researchers, melatonin, a hormone made by a small gland in the brain, may treat blood cancers such as leukemia and lymphoma.

Here’s some good news in the field of cancer treatment. A team of researchers has discovered that a hormone made by a small gland in the brain may treat blood cancers such as leukemia and lymphoma. According to researchers, melatonin, a hormone made by a small gland in the brain, may treat blood cancers such as leukemia and lymphoma.

The findings suggested that melatonin boosts the immune response against cancer cells, inhibits cancer cell growth and protects healthy cells from the toxic effects of chemotherapy. Melatonin is also involved in regulating circadian rhythms, which may help coordinate and synchronise internal body functions, timing of melatonin treatments may be critical to their anti-cancer effects.

Senior author Yang Yang stated that they hope this information will be helpful in the design of studies related to the therapeutic efficacy of melatonin in blood cancers. Melatonin’s anti-cancer actions will help facilitate future basic research and clinical applications, the researchers noted. The study appears in British Journal of Pharmacology.

Follow @htlifeandstyle for more.

Explore Lifestyle stories on Fashion,Health, Relationships, Festivals, Travel, recipe Fitness and Happy Eid 2026 Wishes. Get expert tips, trending updates, and practical ideas to improve your daily routine on Hindustan Times.